Advertisement

Clinical Rheumatology

, Volume 31, Issue 1, pp 1–12 | Cite as

Beyond the joints

Neurological involvement in rheumatoid arthritis
  • Cesar Ramos-RemusEmail author
  • Sergio Duran-Barragan
  • Jose Dionisio Castillo-Ortiz
Review Article

Abstract

Although arthritis is the most notable component, rheumatoid arthritis (RA) is a systemic inflammatory disorder where extra-articular manifestations are common; among them, central and peripheral nervous system involvement is frequent and associated with significant morbidity and, in some cases, reduced life span. It may produce a myriad of symptoms and signs ranging from subtle numbness in a hand, to quadriparesis and sudden death. Central and peripheral neurologic manifestations may arise from structural damage produced by RA in diarthroidal joints, by the systemic inflammatory process of the disease itself or by the drugs used to treat it. Neurologic syndromes may appear suddenly or developed slowly through months, and emerge early or after years of having RA. Neurologic manifestations may be easily overlooked or incorrectly assigned to peripheral arthritis unless the attending physician is aware of these complications. In this article, we review neurologic involvement in RA patients with emphasis on clinical approach for early detection.

Keywords

Compression neuropathies Drug toxicity Dysautonomia Entrapment neuropathies Noncompressive neuropathies Rheumatoid arthritis 

Notes

Disclosures

None.

References

  1. 1.
    Ramos-Remus C, Sierra-Jimenez G, Skeith K et al (2007) Latitude gradient influences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 26:1725–1728PubMedCrossRefGoogle Scholar
  2. 2.
    Badley EM (2008) Rheumatic diseases: the unnoticed elephant in the room. J Rheumatol 35:6–7PubMedGoogle Scholar
  3. 3.
    Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903–911PubMedCrossRefGoogle Scholar
  4. 4.
    Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32:1459–1456PubMedGoogle Scholar
  5. 5.
    Agarwal V, Singh R, Wiclaf et al (2008) A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 27:841–844PubMedCrossRefGoogle Scholar
  6. 6.
    Steinber VL (1960) Neuropathy in rheumatoid disease. Br Med J 1:1600–1603CrossRefGoogle Scholar
  7. 7.
    Weller RO, Bruckner FE, Chamberlain MA (1970) Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 33:592–604PubMedCrossRefGoogle Scholar
  8. 8.
    Pallis CA, Scott JT (1965) Peripheral neuropathy in rheumatoid arthritis. Br Med J 1:1141–1147PubMedCrossRefGoogle Scholar
  9. 9.
    Chamberlain MA, Bruckner FE (1970) Rheumatoid neuropathy. Clinical and electrophysiological features. Ann Rheum Dis 29:609–616PubMedCrossRefGoogle Scholar
  10. 10.
    Lanzillo B, Pappone N, Crisci C et al (1998) Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 41:1196–1202PubMedCrossRefGoogle Scholar
  11. 11.
    Good AE, Christipher RP, Koepke GH, Bender LF, Tarter ME (1965) Peripheral neuropathy associated with rheumatoid arthritis: a clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann Intern Med 63:87–99PubMedGoogle Scholar
  12. 12.
    Genta MS, Genta RM, Gabay C (2006) Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 36:88–98PubMedCrossRefGoogle Scholar
  13. 13.
    Singhal BS, Khadilkar SV, Gursahani RD, Surya N (1995) Vasculitic neuropathy: profile of twenty patients. J Assoc Physicians India 43:459–461PubMedGoogle Scholar
  14. 14.
    Richter C, Wanke L, Steinmetz J, Reinhold-Keller E, Gross WL (2000) Mononeuritis secondary to rheumatoid arthritis responds to etanercept. Rheumatology (Oxford) 39:1436–1437CrossRefGoogle Scholar
  15. 15.
    Mayer DF, Matteson EL (2004) Testicular involvement in rheumatoid vasculitis. Clin Exp Rheumatol 22:S62–S64PubMedGoogle Scholar
  16. 16.
    Puechal X, Said G, Hilliquin P et al (1995) Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 38:1618–1629PubMedCrossRefGoogle Scholar
  17. 17.
    Chatterjee S, Kupsky WJ (2005) Severe proximal myopathy and mononeuritis multiplex in rheumatoid arthritis: manifestations of rheumatoid vasculitis. J Clin Rheumatol 11:50–55PubMedCrossRefGoogle Scholar
  18. 18.
    Armstrong DJ, McCarron MT, Wright GD (2005) Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. J Rheumatol 32:759–760PubMedGoogle Scholar
  19. 19.
    Bayrak AO, Durmus D, Durmaz Y et al (2010) Electrophysiological assessment of polyneuropathic involvement in rheumatoid arthritis: relationships among demographic, clinical and laboratory findings. Neurol Res 32:711–714PubMedCrossRefGoogle Scholar
  20. 20.
    Conn DL, McDuffie FC, Dyck PJ (1972) Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15:135–143PubMedCrossRefGoogle Scholar
  21. 21.
    Scott DG, Bacon PA, Tribe CR (1981) Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60:288–297Google Scholar
  22. 22.
    Muramatsu K, Tanaka H, Taguchi T (2008) Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment. Rheumatol Int 28:951–957PubMedCrossRefGoogle Scholar
  23. 23.
    Canoso JJ, Alvarez-Nemegyei J (2006) Soft tissue rheumatology. In: Lahita RG, Weinstein A (eds) Educational review manual in rheumatology, 3rd edn. Castle Connolly Graduate Medical, New YorkGoogle Scholar
  24. 24.
    Cardenaz Diaz RI, Hernandez Hernandez M, Ramos-Remus C (1994) Anastomosis de Martin–Gruber: Estudio electrofisiológico. Rev Mex Reumatol 9:125–129Google Scholar
  25. 25.
    Boland RA, Kiernan MC (2009) Assessing the accuracy of a combination of clinical tests for identifying carpal tunnel syndrome. J Clin Neurosci 16:929–933PubMedCrossRefGoogle Scholar
  26. 26.
    El MY, Ashour S, Youssef S, Mehanna A, Meky FA (2008) Clinical diagnosis of carpal tunnel syndrome: old tests–new concepts. Jt Bone Spine 75:451–457CrossRefGoogle Scholar
  27. 27.
    Ogawa H, Akaike A, Ishimaru D et al (2007) Posterior interosseous nerve palsy related to rheumatoid synovitis of the elbow. Mod Rheumatol 17:327–329PubMedCrossRefGoogle Scholar
  28. 28.
    Sharp RJ, Wade CM, Hennessy MS, Saxby TS (2003) The role of MRI and ultrasound imaging in Morton’s neuroma and the effect of size of lesion on symptoms. J Bone Jt Surg Br 85:999–1005CrossRefGoogle Scholar
  29. 29.
    Ito H, Neo M, Sakamoto T et al (2009) Subaxial subluxation after atlantoaxial transarticular screw fixation in rheumatoid patients. Eur Spine J 18:869–876PubMedCrossRefGoogle Scholar
  30. 30.
    Collins DN, Barnes CL, FitzRandolph RL (1991) Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res 127–135Google Scholar
  31. 31.
    Neva MH, Kaarela K, Kauppi M (2000) Prevalence of radiological changes in the cervical spine—a cross sectional study after 20 years from presentation of rheumatoid arthritis. J Rheumatol 27:90–93PubMedGoogle Scholar
  32. 32.
    Fujiwara K, Fujimoto M, Owaki H et al (1998) Cervical lesions related to the systemic progression in rheumatoid arthritis. Spine (Phila Pa 1976) 23:2052–2056CrossRefGoogle Scholar
  33. 33.
    Paimela L, Laasonen L, Kankaanpaa E, Leirisalo-Repo M (1997) Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol 24:1280–1284PubMedGoogle Scholar
  34. 34.
    Coutts MB (1934) Atlanto-epistropheal subluxation. Arch Surg 29:297–311CrossRefGoogle Scholar
  35. 35.
    Babini SM, Cocco JA, Babini JC et al (1990) Atlantoaxial subluxation in systemic lupus erythematosus: further evidence of tendinous alterations. J Rheumatol 17:173–177PubMedGoogle Scholar
  36. 36.
    Stuart RA, Maddison PJ (1991) Atlantoaxial subluxation in a patient with mixed connective tissue disease. J Rheumatol 18:1617–1620PubMedGoogle Scholar
  37. 37.
    Laiho K, Kauppi M (2002) The cervical spine in patients with psoriatic arthritis. Ann Rheum Dis 61:650–652PubMedCrossRefGoogle Scholar
  38. 38.
    Fox B, Sahuquillo J, Poca MA, Huguet P, Lience E (1997) Reactive arthritis with a severe lesion of the cervical spine. Br J Rheumatol 36:126–129PubMedCrossRefGoogle Scholar
  39. 39.
    Jordan JM, Obeid LM, Allen NB (1986) Isolated atlantoaxial subluxation as the presenting manifestation of inflammatory bowel disease. Am J Med 80:517–520PubMedCrossRefGoogle Scholar
  40. 40.
    Koss JC, Dalinka MK (1980) Atlantoaxial subluxation in Behcet’s syndrome. AJR Am J Roentgenol 134:392–393PubMedGoogle Scholar
  41. 41.
    Daumen-Legre V, Lafforgue P, Champsaur P et al (1999) Anteroposterior atlantoaxial subluxation in cervical spine osteoarthritis: case reports and review of the literature. J Rheumatol 26:687–691PubMedGoogle Scholar
  42. 42.
    Takasita M, Matsumoto H, Uchinou S, Tsumura H, Torisu T (2000) Atlantoaxial subluxation associated with ossification of posterior longitudinal ligament of the cervical spine. Spine 25:2133–2136PubMedCrossRefGoogle Scholar
  43. 43.
    Verdone F (1999) Anterior atlantoaxial subluxation in a patient with DISH. J Rheumatol 26:1639–1640PubMedGoogle Scholar
  44. 44.
    Herzka A, Sponseller PD, Pyeritz RE (2000) Atlantoaxial rotatory subluxation in patients with Marfan syndrome. A report of three cases. Spine 25:524–526PubMedCrossRefGoogle Scholar
  45. 45.
    Shewell PC, Thompson AG (1996) Atlantoaxial instability in Lesch-Nyhan syndrome. Spine 21:757–762PubMedCrossRefGoogle Scholar
  46. 46.
    Bland JH (1990) Rheumatoid subluxation of the cervical spine. J Rheumatol 17:134–137PubMedGoogle Scholar
  47. 47.
    Sharp J, Purser DW (1961) Spontaneous atlanto-axial dislocation in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 20:47–77PubMedCrossRefGoogle Scholar
  48. 48.
    Martel W (1961) The occipito-atlanto-axial joints in rheumatoid arthritis and ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med 86:223–240PubMedGoogle Scholar
  49. 49.
    Castro S, Verstraete K, Mielants H et al (1994) Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. Clin Exp Rheumatol 12:369–374PubMedGoogle Scholar
  50. 50.
    Komusi T, Munro T, Harth M (1985) Radiologic review: the rheumatoid cervical spine. Semin Arthritis Rheum 14:187–195PubMedCrossRefGoogle Scholar
  51. 51.
    Zikou AK, Alamanos Y, Argyropoulou MI et al (2005) Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study. J Rheumatol 32:801–806PubMedGoogle Scholar
  52. 52.
    Pisitkun P, Pattarowas C, Siriwongpairat P et al (2004) Reappraisal of cervical spine subluxation in Thai patients with rheumatoid arthritis. Clin Rheumatol 23:14–18PubMedCrossRefGoogle Scholar
  53. 53.
    Younes M, Belghali S, Kriaa S et al (2009) Compared imaging of the rheumatoid cervical spine: prevalence study and associated factors. Jt Bone Spine 76:361–368CrossRefGoogle Scholar
  54. 54.
    Resnick D, Niwayama G (1995) Anatomy of individual joints. In: Resnick D (ed) Diagnosis of bone and joint disorders. Saunders, Philadelphia, pp 672–768Google Scholar
  55. 55.
    Bland JH, Boushey DR (1990) Anatomy and physiology of the cervical spine. Semin Arthritis Rheum 20:1–20PubMedCrossRefGoogle Scholar
  56. 56.
    Jackson H (1950) The diagnosis of minimal atlanto-axial subluxation. Br J Radiol 23:672–674PubMedCrossRefGoogle Scholar
  57. 57.
    Hinck VC, Hopkins CE (1960) Measurement of the atlanto-dental interval in the adult. Am J Roentgenol Radium Ther Nucl Med 84:945–951PubMedGoogle Scholar
  58. 58.
    Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL et al (1995) Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 22:2120–2125PubMedGoogle Scholar
  59. 59.
    Ramos-Remus C, Gomez-Vargas A, Hernandez-Chavez A et al (1997) Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol 24:507–510PubMedGoogle Scholar
  60. 60.
    Boden SD, Dodge LD, Bohlman HH, Rechtine GR (1993) Rheumatoid arthritis of the cervical spine. A long-term analysis with predictors of paralysis and recovery. J Bone Jt Surg Am 75:1282–1297Google Scholar
  61. 61.
    Kim DH, Hilibrand AS (2005) Rheumatoid arthritis in the cervical spine. J Am Acad Orthop Surg 13:463–474PubMedGoogle Scholar
  62. 62.
    Kauppi M, Sakaguchi M, Konttinen YT, Hamalainen M (1990) A new method of screening for vertical atlantoaxial dislocation. J Rheumatol 17:167–172PubMedGoogle Scholar
  63. 63.
    Eulderink F, Meijers KA (1976) Pathology of the cervical spine in rheumatoid arthritis: a controlled study of 44 spines. J Pathol 120:91–108PubMedCrossRefGoogle Scholar
  64. 64.
    Bouchaud-Chabot A, Liote F (2002) Cervical spine involvement in rheumatoid arthritis. A review. Jt Bone Spine 69:141–154CrossRefGoogle Scholar
  65. 65.
    Raskin RJ, Schnapf DJ, Wolf CR, Killian PJ, Lawless OJ (1983) Computerized tomography in evaluation of atlantoaxial subluxation in rheumatoid arthritis. J Rheumatol 10:33–41PubMedGoogle Scholar
  66. 66.
    Braunstein EM, Weissman BN, Seltzer SE et al (1984) Computed tomography and conventional radiographs of the craniocervical region in rheumatoid arthritis. A comparison. Arthritis Rheum 27:26–31PubMedCrossRefGoogle Scholar
  67. 67.
    Breedveld FC, Algra PR, Vielvoye CJ, Cats A (1987) Magnetic resonance imaging in the evaluation of patients with rheumatoid arthritis and subluxations of the cervical spine. Arthritis Rheum 30:624–629PubMedCrossRefGoogle Scholar
  68. 68.
    Stiskal MA, Neuhold A, Szolar DH et al (1995) Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. AJR Am J Roentgenol 165:585–592PubMedGoogle Scholar
  69. 69.
    Bell GR, Stearns KL (1991) Flexion–extension MRI of the upper rheumatoid cervical spine. Orthopedics 14:969–973PubMedGoogle Scholar
  70. 70.
    Neva MH, Hakkinen A, Makinen H et al (2006) High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis 65:884–888PubMedCrossRefGoogle Scholar
  71. 71.
    Lopez-Olivo MA, Andrabi PR, Palla SL, Suarez-Almazor ME (2011) Use of cervical spine radiographs in patients with rheumatoid arthritis undergoing general anesthesia. Clin Rheumatol (in press)Google Scholar
  72. 72.
    Messeter KH, Pettersson KI (1980) Endotracheal intubation with the fibre-optic bronchoscope. Anaesthesia 35:294–298PubMedCrossRefGoogle Scholar
  73. 73.
    Riise T, Jacobsen BK, Gran JT (2001) High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation. J Rheumatol 28:2425–29PubMedGoogle Scholar
  74. 74.
    Paus AC, Steen H, Roislien J, Mowinckel P, Teigland J (2008) High mortality rate in rheumatoid arthritis with subluxation of the cervical spine$$ a cohort study of operated and nonoperated patients. Spine (Phila PA 1976) 33:2278–2283CrossRefGoogle Scholar
  75. 75.
    Shoda N, Seichi A, Takeshita K et al (2009) Sleep apnea in rheumatoid arthritis patients with occipitocervical lesions: the prevalence and associated radiographic features. Eur Spine J 18:905–910PubMedCrossRefGoogle Scholar
  76. 76.
    Zikou AK, Argyropoulou MI, Voulgari PV et al (2006) Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J Rheumatol 33:219–223PubMedGoogle Scholar
  77. 77.
    Mukai Y, Hosono N, Sakaura H et al (2007) Sagittal alignment of the subaxial cervical spine after C1–C2 transarticular screw fixation in rheumatoid arthritis. J Spinal Disord Tech 20:436–441PubMedCrossRefGoogle Scholar
  78. 78.
    Mrabet D, Meddeb N, Ajlani H, Sahli H, Sellami S (2007) Cerebral vasculitis in a patient with rheumatoid arthritis. Joint Bone Spine 74:201–204PubMedCrossRefGoogle Scholar
  79. 79.
    Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288PubMedGoogle Scholar
  80. 80.
    Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 18:258–266PubMedCrossRefGoogle Scholar
  81. 81.
    Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL (1979) Rheumatoid meningitis: a localized immune process. Ann Intern Med 90:786–789PubMedGoogle Scholar
  82. 82.
    Jackson CG, Chess RL, Ward JR (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11:237–240PubMedGoogle Scholar
  83. 83.
    Schmid L, Muller M, Treumann T et al (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60:1632–1634PubMedCrossRefGoogle Scholar
  84. 84.
    Catananti C, Mastropaolo S, Calabrese C, Silveri MC, Onder G (2010) A case of normal-pressure hydrocephalus associated with rheumatoid arthritis. Aging Clin Exp Res 22:189–191PubMedGoogle Scholar
  85. 85.
    Bruggemann N, Gottschalk S, Holl-Ulrich K et al (2010) Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology. J Neurol Neurosurg Psychiatry 81:294–298PubMedCrossRefGoogle Scholar
  86. 86.
    Ikeda K, Takazawa T, Ito H et al (2010) Rheumatoid leptomeningitis: radiological alteration of cerebral hypoperfusion and subarachnoid lesions. Intern Med 49:1911–1916PubMedCrossRefGoogle Scholar
  87. 87.
    Schilling U, Muck R, Heidemann E (2004) Lead poisoning after ingestion of ayurvedic drugs. Med Klin (Munich) 99:476–480CrossRefGoogle Scholar
  88. 88.
    Karri SK, Saper RB, Kales SN (2008) Lead encephalopathy due to traditional medicines. Curr Drug Saf 3:54–59PubMedCrossRefGoogle Scholar
  89. 89.
    Benyamin RM, Vallejo R, Kramer J, Rafeyan R (2008) Corticosteroid induced psychosis in the pain management setting. Pain Physician 11:917–920PubMedGoogle Scholar
  90. 90.
    Perantie DC, Brown ES (2002) Corticosteroids, immune suppression, and psychosis. Curr Psychiatry Rep 4:171–176PubMedCrossRefGoogle Scholar
  91. 91.
    Wolkowitz OM, Lupien SJ, Bigler E, Levin RB, Canick J (2004) The “steroid dementia syndrome”: an unrecognized complication of glucocorticoid treatment. Ann N Y Acad Sci 1032:191–194PubMedCrossRefGoogle Scholar
  92. 92.
    Brown ES, Chandler PA (2001) Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3:17–21PubMedCrossRefGoogle Scholar
  93. 93.
    Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122PubMedCrossRefGoogle Scholar
  94. 94.
    Sapolsky RM (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1:1–19PubMedCrossRefGoogle Scholar
  95. 95.
    Alderson AL, Novack TA (2002) Neurophysiological and clinical aspects of glucocorticoids and memory: a review. J Clin Exp Neuropsychol 24:335–355PubMedCrossRefGoogle Scholar
  96. 96.
    Gonzalez-Perez O, Ramos-Remus C, Garcia-Estrada J, Luquin S (2001) Prednisone induces anxiety and glial cerebral changes in rats. J Rheumatol 28:2529–2534PubMedGoogle Scholar
  97. 97.
    Ramos-Remus C, Gonzalez-Castaneda RE, Gonzalez-Perez O, Luquin S, Garcia-Estrada J (2002) Prednisone induces cognitive dysfunction, neuronal degeneration, and reactive gliosis in rats. J Investig Med 50:458–464PubMedCrossRefGoogle Scholar
  98. 98.
    Hoppmann RA, Peden JG, Ober SK (1991) Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med 151:1309–1313PubMedCrossRefGoogle Scholar
  99. 99.
    Rodriguez SC, Olguin AM, Miralles CP, Viladrich PF (2006) Characteristics of meningitis caused by Ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine (Baltimore) 85:214–220CrossRefGoogle Scholar
  100. 100.
    Simon LS, Mills JA (1980) Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts). N Engl J Med 302:1179–1185PubMedCrossRefGoogle Scholar
  101. 101.
    Horn AC, Jarrett SW (1997) Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann Pharmacother 31:1009–1011PubMedGoogle Scholar
  102. 102.
    Quinn CT, Kamen BA (1996) A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med 44:522–530PubMedGoogle Scholar
  103. 103.
    Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41:1906–1911PubMedCrossRefGoogle Scholar
  104. 104.
    Rynes RI (1996) Ophthalmologic considerations in using antimalarials in the United States. Lupus 5(Suppl 1):S73–S74PubMedCrossRefGoogle Scholar
  105. 105.
    Rynes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36:799–805PubMedCrossRefGoogle Scholar
  106. 106.
    Johansen PB, Gran JT (1998) Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 16:472–474PubMedGoogle Scholar
  107. 107.
    Seckin U, Ozoran K, Ikinciogullari A, Borman P, Bostan EE (2000) Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 19:203–204PubMedCrossRefGoogle Scholar
  108. 108.
    Hadi U, Nuwayhid N, Hasbini AS (1996) Chloroquine ototoxicity: an idiosyncratic phenomenon. Otolaryngol Head Neck Surg 114:491–493PubMedCrossRefGoogle Scholar
  109. 109.
    Bernard P (1985) Alterations of auditory evoked potentials during the course of chloroquine treatment. Acta Otolaryngol 99:387–392PubMedCrossRefGoogle Scholar
  110. 110.
    Scherbel AL, Harrison JW, Atdjian M (1958) Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q 25:95–111PubMedGoogle Scholar
  111. 111.
    Meier CR, Wilcock K, Jick SS (2004) The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf 27:203–213PubMedCrossRefGoogle Scholar
  112. 112.
    Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell AS (1995) Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol 34:166–170PubMedCrossRefGoogle Scholar
  113. 113.
    Casado E, Gratacos J, Tolosa C et al (2006) Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 65:385–390PubMedCrossRefGoogle Scholar
  114. 114.
    Richards BL, Spies J, McGill N et al (2007) Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern Med J 37:101–107PubMedCrossRefGoogle Scholar
  115. 115.
    Antonio-Valdiviezo A, Pena-Santos G, Martinez-Torres J (2010) Peripheral neuropathy caused by leflunomide. A case reported with a brief review. Rev Med Inst Mex Seguro Soc 48:567–570PubMedGoogle Scholar
  116. 116.
    Bonnel RA, Graham DJ (2004) Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther 75:580–585PubMedCrossRefGoogle Scholar
  117. 117.
    Martin K, Bentaberry F, Dumoulin C et al (2005) Neuropathy associated with leflunomide: a case series. Ann Rheum Dis 64:649–650PubMedCrossRefGoogle Scholar
  118. 118.
    Martin K, Bentaberry F, Dumoulin C et al (2007) Peripheral neuropathy associated with leflunomide: is there a risk patient profile? Pharmacoepidemiol Drug Saf 16:74–78PubMedCrossRefGoogle Scholar
  119. 119.
    Bharadwaj A, Haroon N (2004) Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford) 43:934CrossRefGoogle Scholar
  120. 120.
    Tilelli JA, Heinrichs MM (1997) Adverse reactions to parenteral gold salts. Lancet 349:853PubMedCrossRefGoogle Scholar
  121. 121.
    Fam AG, Gordon DA, Sarkozi J et al (1984) Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol 11:700–706PubMedGoogle Scholar
  122. 122.
    Petiot P, Charles N, Vial C et al (1993) Neurological complications caused by gold salts. Nosologic report apropos of a case. Rev Neurol (Paris) 149:562–565Google Scholar
  123. 123.
    Goy JJ, Stauffer JC, Deruaz JP et al (1989) Myopathy as possible side-effect of cyclosporin. Lancet 1:1446–1447PubMedCrossRefGoogle Scholar
  124. 124.
    Noppen M, Velkeniers B, Dierckx R, Bruyland M, Vanhaelst L (1987) Cyclosporine and myopathy. Ann Intern Med 107:945–946PubMedGoogle Scholar
  125. 125.
    Owczarek J, Jasinska M, Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57:23–34PubMedGoogle Scholar
  126. 126.
    Schwartz RB, Bravo SM, Klufas RA et al (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165:627–631PubMedGoogle Scholar
  127. 127.
    Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346PubMedCrossRefGoogle Scholar
  128. 128.
    Kumar D, Bouldin TW, Berger RG (2010) A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis Rheum 62:3191–3195PubMedCrossRefGoogle Scholar
  129. 129.
    Lozeron P, Denier C, Lacroix C, Adams D (2009) Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 66:490–497PubMedCrossRefGoogle Scholar
  130. 130.
    Kur-Zalewska J, Swarowska-Knap J, Tlustochowicz W (2008) Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn 118:234–237PubMedGoogle Scholar
  131. 131.
    Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869PubMedCrossRefGoogle Scholar
  132. 132.
    Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain–Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429–1434PubMedCrossRefGoogle Scholar
  133. 133.
    Alshekhlee A, Basiri K, Miles JD, Ahmad SA, Katirji B (2010) Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 41:723–727PubMedCrossRefGoogle Scholar
  134. 134.
    Bosch X, Saiz A, Ramos-Casals M (2011) Monoclonal antibody therapy-associated neurological disorders. Nat Rev Neurol 7:165–172PubMedCrossRefGoogle Scholar
  135. 135.
    Lynch K, Farrell M (2010) Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment. Clin Rheumatol 29:1201–1204PubMedCrossRefGoogle Scholar
  136. 136.
    Calabrese LH, Molloy ES (2008) Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 67(Suppl 3):iii64–iii65PubMedCrossRefGoogle Scholar
  137. 137.
  138. 138.
    Carson KR, Focosi D, Major EO et al (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816–824PubMedCrossRefGoogle Scholar
  139. 139.
    Lima MA, Drislane FW, Koralnik IJ (2006) Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 66:262–264PubMedCrossRefGoogle Scholar
  140. 140.
    Alloway JA, Mitchell SR (1993) Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol 20:409–411PubMedGoogle Scholar
  141. 141.
    Takahashi K, Ogita T, Okudaira H et al (1986) d-Penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 29:560–564PubMedCrossRefGoogle Scholar
  142. 142.
    Chappel R, Willems J (1996) d-Penicillamine-induced myositis in rheumatoid arthritis. Clin Rheumatol 15:86–87PubMedCrossRefGoogle Scholar
  143. 143.
    Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL (1987) Penicillamine induced polymyositis and dermatomyositis. J Rheumatol 14:995–1001PubMedGoogle Scholar
  144. 144.
    Halla JT, Fallahi S, Koopman WJ (1984) Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature. Am J Med 77:719–722PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2011

Authors and Affiliations

  • Cesar Ramos-Remus
    • 1
    • 2
    • 4
    Email author
  • Sergio Duran-Barragan
    • 1
    • 3
  • Jose Dionisio Castillo-Ortiz
    • 1
  1. 1.Unidad de Investigación en Enfermedades Crónico-DegenerativasGuadalajaraMexico
  2. 2.Hospital General Regional 45Instituto Mexicano del Seguro SocialGuadalajaraMexico
  3. 3.Centro Universitario del SurUniversidad de GuadalajaraCd. GuzmánMexico
  4. 4.ProvidenciaMexico

Personalised recommendations